 |
市场调查报告书
商品编码
1630571
全球临床诊断的 6 大成长机会：2025 年Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025 |
||||||
新的测试核准和测试自动化解决方案推动转型成长
诊断占医疗总成本的2-3%，影响70%的临床决策，是支持精准医疗各阶段的无声组成部分，包括风险分类、筛检、早期诊断、预后、监测和復发一个冠军。
发现和转化基于血液的神经生物标誌物的独特机会、寻求监管核准的药物诊断组合的持续增长以及用于改进和完善治疗决策的快速抗菌药物耐药性诊断我们需要诊断应用的内置适应性来改变医疗保健途径。此外，鑑于该领域面临的持续挑战，包括病理学人才短缺、准确性问题、价格和资源分配不平等，云端基础的解决方案、远端存取和即时资料监控正在经历前所未有的演变，预计将重塑世界业务。
随着该领域经历了治疗决策和精准路径转型的巨大转变，技术进步、市场需求和患者期望的三位一体正在改变全球诊断生态系统。随着公司寻求降低产品和服务价格、减少资本支出并获得资金以改善网路安全，对更有效率诊断的需求不断增加。相关人员的关键是透过仪表板和即时分析升级产品的资讯技术 (IT) 组件，从而推动对可提供精准治疗的整合、可扩展资料库诊断模型的需求。
目录
2025 年的主要成长机会
- 策略要务
- 六大成长机会
- 成长机会 1：LIMS
- 成长机会2：NGS资讯学
- 成长机会3：智慧实验室解决方案
- 成长机会 4：伴随诊断
- 增长机会 5：神经血液测试
- 成长机会 6：快速抗菌药物抗药性诊断
- 下一步
- 免责声明
Approval of New Tests and Laboratory Automation Solutions are Driving Transformational Growth
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse.
The discovery and translation of blood-based neurology biomarkers, sustained growth in drug-diagnostic combinations seeking regulatory approval, and unique opportunities in rapid antimicrobial resistance diagnostics necessitate built-in adaptability in diagnostics applications to improve therapeutic decisions and transform precision healthcare pathways. Moreover, given the persistent challenges the sector is facing, including the pathology workforce shortage, accuracy concerns, and uneven distribution of prices and resources, cloud-based solutions, remote access, and real-time data monitoring are evolving unprecedentedly and promising to reshape operations globally.
As the sector undergoes a seismic shift to improve therapeutic decisions and transform precision pathways, the trifecta of technological advancements, market demands, and patient expectations is transforming the global diagnostics ecosystem. The need to make products and services more affordable, reduce capital expenditure, and free up funds to improve cybersecurity will forge demand for greater diagnostics efficiency. The key for stakeholders will be to upgrade products' information technology (IT) components through dashboards and real-time analytics and forge demand for a unified, scalable data-based diagnostic model capable of delivering precision care.
Table of Contents
Top Growth Opportunities for 2025
- Strategic Imperatives
- Top 6 Growth Opportunities
- Growth Opportunity 1: LIMS
- Growth Opportunity 2: NGS Informatics
- Growth Opportunity 3: Smart Lab Solutions
- Growth Opportunity 4: CDx
- Growth Opportunity 5: Neurology Blood Tests
- Growth Opportunity 6: Rapid Antimicrobial Resistance Diagnostics
- Next Steps
- Legal Disclaimer
